Clinical Trial Update: Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock [NA]

View source ↗

Summary

ClinicalTrials.gov indicates the pilot Bevacizumab study in septic shock has been withdrawn; sponsor is Beth Israel Deaconess Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Septic Shock | NA | Status: WITHDRAWN